Francis Duhay - 15 Sep 2025 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Role
Director
Signature
/s/ Francis Duhay
Issuer symbol
NVNO
Transactions as of
15 Sep 2025
Net transactions value
-$4,067
Form type
4
Filing time
17 Sep 2025, 09:00:02 UTC
Previous filing
03 Jan 2025
Next filing
15 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Duhay Francis Director C/O ENVVENO MEDICAL CORPORATION,, 70 DOPPLER, IRVINE /s/ Francis Duhay 17 Sep 2025 0001760582

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVNO Common Stock Sale $4,067 -4,900 -4.8% $0.8300 97,444 15 Sep 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.
F2 This transaction was executed in multiple trades during the day at prices ranging from $0.8205 to $0.84, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed.